JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Immunostimulatory activities of Bacillus simplex DR-834 to carp (Cyprinus carpio).

A bacterial strain, designated DR-834 and producing immunostimulatory activities to carp (Cyprinus carpio), was isolated from Qinghai-Tibetan Plateau permafrost soil. Cultural characteristic studies suggested that this strain belongs to the genus Bacillus. The nucleotide sequence of the 16S rRNA gene of strain DR-834 exhibited close similarity (99%) with the 16S rRNA gene of Bacillus simplex. Two compounds showing potent activity were isolated from secondary metabolites of the strain through bioassay-guided isolation techniques and identified by spectral data (infrared, nuclear magnetic resonance and mass spectrometry) as: (1) 4-trans-hydroxy-l-proline and (2) cyclo-(l-Pro-Gly)(2). They were found to be significantly increased the selected innate immune function parameters, serum SOD activity, serum lysozyme activity, serum bactericidal activity, superoxide anion production and phagocytic activity by isolated blood leucocytes. The effects of two compounds on immune-related genes expression were further investigated. The outcomes of real-time quantitative polymerase chain reaction (RQ-PCR) proved that the transcribing level of interleukin 1beta (IL-1beta) and inducible nitric oxide synthase (iNOS) mRNA in the blood have been augmented by 4-trans-hydroxy-l-proline and cyclo-(l-Pro-Gly)(2). Compounds 1 and 2 administration the challenge with live Aeromonas hydrophila decreased the percentage mortality in the experimental groups with the consequence increase in relative percent survival (RPS) values. Compound 2 produced the highest protection with the RPS values of 87.50, 77.78, 55.56 and 55.56 after 1, 2, 3 and 4 weeks, respectively. The study indicates that the isolated compounds could be positively influence the immune response and protect the heath status of carp against A. hydrophila infection.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app